Genetic background affects susceptibility to tumoral stem cell reprogramming

References

• Vicente-Dueñas C, Romero-Camarero I, Cobaleda C, Sánchez-García I. Function of oncogenes in cancer development: a changing paradigm. EMBO J 2013; 32:1502 - 13; http://dx.doi.org/10.1038/emboj.2013.97; PMID: 23632857
   PubMed Web of Science ®Google Scholar
• Cobaleda C, Sánchez-García I. Back to the beginning: The initiation of cancer. Bioessays 2013; 35:413; http://dx.doi.org/10.1002/bies.201300024; PMID: 23553938
   PubMed Web of Science ®Google Scholar
• Sánchez-García I, Vicente-Dueñas C, Cobaleda C. The theoretical basis of cancer-stem-cell-based therapeutics of cancer: can it be put into practice?. Bioessays 2007; 29:1269 - 80; http://dx.doi.org/10.1002/bies.20679; PMID: 18022789
   PubMed Web of Science ®Google Scholar
• Pérez-Caro M, Cobaleda C, González-Herrero I, Vicente-Dueñas C, Bermejo-Rodríguez C, Sánchez-Beato M, et al. Cancer induction by restriction of oncogene expression to the stem cell compartment. EMBO J 2009; 28:8 - 20; http://dx.doi.org/10.1038/emboj.2008.253; PMID: 19037256
   PubMed Web of Science ®Google Scholar
• Vicente-Dueñas C, Pérez-Caro M, Abollo-Jiménez F, Cobaleda C, Sánchez-García I. Stem-cell driven cancer: “hands-off” regulation of cancer development. Cell Cycle 2009; 8:1314 - 8; http://dx.doi.org/10.4161/cc.8.9.8217; PMID: 19279406
   PubMed Web of Science ®Google Scholar
• Sánchez-García I. The crossroads of oncogenesis and metastasis. N Engl J Med 2009; 360:297 - 9; http://dx.doi.org/10.1056/NEJMcibr0808031; PMID: 19144947
   PubMed Web of Science ®Google Scholar
• Sánchez-García I. Getting to the stem of cancer. Semin Cancer Biol 2010; 20:63 - 4; http://dx.doi.org/10.1016/j.semcancer.2010.05.001; PMID: 20451615
   PubMed Web of Science ®Google Scholar
• Castellanos A, Vicente-Dueñas C, Campos-Sánchez E, Cruz JJ, García-Criado FJ, García-Cenador MB, et al. Cancer as a reprogramming-like disease: implications in tumor development and treatment. Semin Cancer Biol 2010; 20:93 - 7; http://dx.doi.org/10.1016/j.semcancer.2010.02.001; PMID: 20188174
   PubMed Web of Science ®Google Scholar
• González-Herrero I, Vicente-Dueñas C, Orfao A, Flores T, Jiménez R, Cobaleda C, et al. Bcl2 is not required for the development and maintenance of leukemia stem cells in mice. Carcinogenesis 2010; 31:1292 - 7; http://dx.doi.org/10.1093/carcin/bgq062; PMID: 20299524
   PubMed Web of Science ®Google Scholar
• Vicente-Dueñas C, Barajas-Diego M, Romero-Camarero I, González-Herrero I, Flores T, Sánchez-García I. Essential role for telomerase in chronic myeloid leukemia induced by BCR-ABL in mice. Oncotarget 2012; 3:261 - 6; PMID: 22408137
   PubMed Web of Science ®Google Scholar
• Vicente-Dueñas C, Fontán L, Gonzalez-Herrero I, Romero-Camarero I, Segura V, Aznar MA, et al. Expression of MALT1 oncogene in hematopoietic stem/progenitor cells recapitulates the pathogenesis of human lymphoma in mice. Proc Natl Acad Sci U S A 2012; 109:10534 - 9; http://dx.doi.org/10.1073/pnas.1204127109; PMID: 22689981
   PubMed Web of Science ®Google Scholar
• Vicente-Dueñas C, Cobaleda C, Martínez-Climent JÁ, Sánchez-García I. MALT lymphoma meets stem cells. Cell Cycle 2012; 11:2961 - 2; http://dx.doi.org/10.4161/cc.21264; PMID: 22825253
   PubMed Web of Science ®Google Scholar
• Vicente-Dueñas C, Romero-Camarero I, González-Herrero I, Alonso-Escudero E, Abollo-Jiménez F, Jiang X, et al. A novel molecular mechanism involved in multiple myeloma development revealed by targeting MafB to haematopoietic progenitors. EMBO J 2012; 31:3704 - 17; http://dx.doi.org/10.1038/emboj.2012.227; PMID: 22903061
   PubMed Web of Science ®Google Scholar
• Vicente-Dueñas C, Romero-Camarero I, García-Criado FJ, Cobaleda C, Sánchez-García I. The cellular architecture of multiple myeloma. Cell Cycle 2012; 11:3715 - 7; http://dx.doi.org/10.4161/cc.22178; PMID: 22983005
   PubMed Web of Science ®Google Scholar
• Vicente-Dueñas C, González-Herrero I, García Cenador MB, García Criado FJ, Sánchez-García I. Loss of p53 exacerbates multiple myeloma phenotype by facilitating the reprogramming of hematopoietic stem/progenitor cells to malignant plasma cells by MafB. Cell Cycle 2012; 11:1479 - 80; http://dx.doi.org/10.4161/cc.22186; PMID: 22487683
   PubMed Web of Science ®Google Scholar
• Romero-Camarero I, Jiang X, Natkunam Y, Lu X, Vicente-Dueñas C, Gonzalez-Herrero I, et al. Germinal centre protein HGAL promotes lymphoid hyperplasia and amyloidosis via BCR-mediated Syk activation. Nat Commun 2013; 4:1338; http://dx.doi.org/10.1038/ncomms2334; PMID: 23299888
   PubMed Web of Science ®Google Scholar
• Velasco-Hernández T, Vicente-Dueñas C, Sánchez-García I, Martin-Zanca D. p53 restoration kills primitive leukemia cells in vivo and increases survival of leukemic mice. Cell Cycle 2013; 12:122 - 32; http://dx.doi.org/10.4161/cc.23031; PMID: 23255106
   PubMed Web of Science ®Google Scholar
• Chomel JC, Bonnet ML, Sorel N, Bertrand A, Meunier MC, Fichelson S, et al. Leukemic stem cell persistence in chronic myeloid leukemia patients with sustained undetectable molecular residual disease. Blood 2011; 118:3657 - 60; http://dx.doi.org/10.1182/blood-2011-02-335497; PMID: 21791426
   PubMed Web of Science ®Google Scholar
• Chu S, McDonald T, Lin A, Chakraborty S, Huang Q, Snyder DS, et al. Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatment. Blood 2011; 118:5565 - 72; http://dx.doi.org/10.1182/blood-2010-12-327437; PMID: 21931114
   PubMed Web of Science ®Google Scholar
• Kumari A, Brendel C, Hochhaus A, Neubauer A, Burchert A. Low BCR-ABL expression levels in hematopoietic precursor cells enable persistence of chronic myeloid leukemia under imatinib. Blood 2012; 119:530 - 9; http://dx.doi.org/10.1182/blood-2010-08-303495; PMID: 22101898
   PubMed Web of Science ®Google Scholar
• Hamilton A, Helgason GV, Schemionek M, Zhang B, Myssina S, Allan EK, et al. Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival. Blood 2012; 119:1501 - 10; http://dx.doi.org/10.1182/blood-2010-12-326843; PMID: 22184410
   PubMed Web of Science ®Google Scholar